Skip to content
healthcare.dev

DESVENLAFAXINE

NDC 68071-3790, DESVENLAFAXINE, tablet, extended release, from NuCare Pharmaceuticals,Inc..

Product NDC
68071-3790
Status
Listed
Labeler
NuCare Pharmaceuticals,Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA204028
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68071-3790 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DESVENLAFAXINE SUCCINATE50 mg/1

Pharmacologic classes

Cytochrome P450 2D6 Inhibitors [MoA]; Norepinephrine Uptake Inhibitors [MoA]; Serotonin Uptake Inhibitors [MoA]; Serotonin and Norepinephrine Reuptake Inhibitor [EPC]

Package NDCNDC-11Package
68071-3790-36807137900330 TABLET, EXTENDED RELEASE in 1 BOTTLE (68071-3790-3)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2dce1542-ead5-1b24-e063-6294a90a6df0

Use it

Look up 68071-3790 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68071-3790 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68071-3790. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.